{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T18:32:20Z","timestamp":1772735540956,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T00:00:00Z","timestamp":1547164800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI14C1529"],"award-info":[{"award-number":["HI14C1529"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13287-018-1127-3","type":"journal-article","created":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T12:10:05Z","timestamp":1547208605000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["The therapeutic potential of induced hepatocyte-like cells generated by direct reprogramming on hepatic fibrosis"],"prefix":"10.1186","volume":"10","author":[{"given":"Suhyun","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seon","family":"In Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonghun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seoyeon","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohee","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sera","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonghwa","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wonseok","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyun-Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Wook","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Han","family":"Paik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,11]]},"reference":[{"issue":"2","key":"1127_CR1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.7861\/clinmedicine.11-2-179","volume":"11","author":"J Fallowfield","year":"2011","unstructured":"Fallowfield J, Hayes P. Pathogenesis and treatment of hepatic fibrosis: is cirrhosis reversible? Clin Med (Lond). 2011;11(2):179\u201383.","journal-title":"Clin Med (Lond)"},{"issue":"4","key":"1127_CR2","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1159\/000374098","volume":"33","author":"SL Friedman","year":"2015","unstructured":"Friedman SL. Hepatic fibrosis: emerging therapies. Dig Dis. 2015;33(4):504\u20137.","journal-title":"Dig Dis"},{"key":"1127_CR3","first-page":"30","volume":"4","author":"N Itoh","year":"2016","unstructured":"Itoh N, Nakayama Y, Konishi M. Roles of FGFs as paracrine or endocrine signals in liver development, health, and disease. Front Cell Dev Biol. 2016;4:30.","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"1127_CR4","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3350\/cmh.2017.0078","volume":"23","author":"RC Lo","year":"2017","unstructured":"Lo RC, Kim H. Histopathological evaluation of liver fibrosis and cirrhosis regression. Clin Mol Hepatol. 2017;23(4):302\u20137.","journal-title":"Clin Mol Hepatol"},{"issue":"5","key":"1127_CR5","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1586\/17474124.2016.1134313","volume":"10","author":"T Matsumoto","year":"2016","unstructured":"Matsumoto T, Takami T, Sakaida I. Cell transplantation as a non-invasive strategy for treating liver fibrosis. Expert Rev Gastroenterol Hepatol. 2016;10(5):639\u201348.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"6","key":"1127_CR6","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.stem.2016.05.007","volume":"18","author":"Y Guan","year":"2016","unstructured":"Guan Y, Xu D, Peltz G. Treating liver fibrosis: (re)programmed to succeed. Cell Stem Cell. 2016;18(6):683\u20134.","journal-title":"Cell Stem Cell"},{"issue":"3","key":"1127_CR7","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3350\/cmh.2018.1005","volume":"24","author":"Korean Association for the Study of the L","year":"2018","unstructured":"Korean Association for the Study of the L. KASL clinical practice guidelines for liver cirrhosis: ascites and related complications. Clin Mol Hepatol. 2018;24(3):230\u201377.","journal-title":"Clin Mol Hepatol"},{"issue":"1 Suppl","key":"1127_CR8","doi-asserted-by":"publisher","first-page":"S157","DOI":"10.1016\/j.jhep.2015.02.040","volume":"62","author":"SJ Forbes","year":"2015","unstructured":"Forbes SJ, Gupta S, Dhawan A. Cell therapy for liver disease: from liver transplantation to cell factory. J Hepatol. 2015;62(1 Suppl):S157\u201369.","journal-title":"J Hepatol"},{"issue":"10","key":"1127_CR9","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1002\/stem.1457","volume":"31","author":"G Lanzoni","year":"2013","unstructured":"Lanzoni G, Oikawa T, Wang Y, Cui CB, Carpino G, Cardinale V, Gerber D, Gabriel M, Dominguez-Bendala J, Furth ME, et al. Concise review: clinical programs of stem cell therapies for liver and pancreas. Stem Cells. 2013;31(10):2047\u201360.","journal-title":"Stem Cells"},{"issue":"1","key":"1127_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/scrt164","volume":"4","author":"AM AlZoubi","year":"2013","unstructured":"AlZoubi AM, Khalifeh F. The effectiveness of stem cell therapies on health-related quality of life and life expectancy in comparison with conventional supportive medical treatment in patients suffering from end-stage liver disease. Stem Cell Res Ther. 2013;4(1):16.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"1127_CR11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jhep.2013.01.018","volume":"59","author":"Z Zhang","year":"2013","unstructured":"Zhang Z, Wang FS. Stem cell therapies for liver failure and cirrhosis. J Hepatol. 2013;59(1):183\u20135.","journal-title":"J Hepatol"},{"issue":"4","key":"1127_CR12","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663\u201376.","journal-title":"Cell"},{"issue":"3","key":"1127_CR13","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/jcp.22000","volume":"222","author":"W Li","year":"2010","unstructured":"Li W, Wang D, Qin J, Liu C, Zhang Q, Zhang X, Yu X, Lahn BT, Mao FF, Xiang AP. Generation of functional hepatocytes from mouse induced pluripotent stem cells. J Cell Physiol. 2010;222(3):492\u2013501.","journal-title":"J Cell Physiol"},{"issue":"5","key":"1127_CR14","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.jhep.2016.01.004","volume":"64","author":"Y Nagamoto","year":"2016","unstructured":"Nagamoto Y, Takayama K, Ohashi K, Okamoto R, Sakurai F, Tachibana M, Kawabata K, Mizuguchi H. Transplantation of a human iPSC-derived hepatocyte sheet increases survival in mice with acute liver failure. J Hepatol. 2016;64(5):1068\u201375.","journal-title":"J Hepatol"},{"issue":"2","key":"1127_CR15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.32607\/20758251-2010-2-2-18-27","volume":"2","author":"SP Medvedev","year":"2010","unstructured":"Medvedev SP, Shevchenko AI, Zakian SM. Induced pluripotent stem cells: problems and advantages when applying them in regenerative medicine. Acta Nat. 2010;2(2):18\u201328.","journal-title":"Acta Nat"},{"issue":"7356","key":"1127_CR16","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/nature10116","volume":"475","author":"P Huang","year":"2011","unstructured":"Huang P, He Z, Ji S, Sun H, Xiang D, Liu C, Hu Y, Wang X, Hui L. Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. Nature. 2011;475(7356):386\u20139.","journal-title":"Nature"},{"key":"1127_CR17","doi-asserted-by":"crossref","unstructured":"Lim KT, Lee SC, Gao Y, Kim KP, Song G, An SY, Adachi K, Jang YJ, Kim J, Oh KJ, et al. Small molecules facilitate single factor-mediated hepatic reprogramming. Cell Rep. 2016;15(4):814-29.","DOI":"10.1016\/j.celrep.2016.03.071"},{"issue":"4","key":"1127_CR18","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.stem.2012.02.021","volume":"10","author":"DW Han","year":"2012","unstructured":"Han DW, Tapia N, Hermann A, Hemmer K, Hoing S, Arauzo-Bravo MJ, Zaehres H, Wu G, Frank S, Moritz S, et al. Direct reprogramming of fibroblasts into neural stem cells by defined factors. Cell Stem Cell. 2012;10(4):465\u201372.","journal-title":"Cell Stem Cell"},{"issue":"9","key":"1127_CR19","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/cr.2011.107","volume":"21","author":"JH Moon","year":"2011","unstructured":"Moon JH, Heo JS, Kim JS, Jun EK, Lee JH, Kim A, Kim J, Whang KY, Kang YK, Yeo S, et al. Reprogramming fibroblasts into induced pluripotent stem cells with Bmi1. Cell Res. 2011;21(9):1305\u201315.","journal-title":"Cell Res"},{"issue":"7356","key":"1127_CR20","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/nature10263","volume":"475","author":"S Sekiya","year":"2011","unstructured":"Sekiya S, Suzuki A. Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors. Nature. 2011;475(7356):390\u20133.","journal-title":"Nature"},{"issue":"3","key":"1127_CR21","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/hep.1840190330","volume":"19","author":"S Gupta","year":"1994","unstructured":"Gupta S, Lee CD, Vemuru RP, Bhargava KK. 111Indium labeling of hepatocytes for analysis of short-term biodistribution of transplanted cells. Hepatology. 1994;19(3):750\u20137.","journal-title":"Hepatology"},{"key":"1127_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/978-1-59745-201-4_7","volume":"481","author":"J Seppen","year":"2009","unstructured":"Seppen J, Filali EE, Elferink RO. Small animal models of hepatocyte transplantation. Methods Mol Biol. 2009;481:75\u201382.","journal-title":"Methods Mol Biol"},{"key":"1127_CR23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/978-1-59745-201-4_8","volume":"481","author":"A Weber","year":"2009","unstructured":"Weber A, Groyer-Picard MT, Dagher I. Hepatocyte transplantation techniques: large animal models. Methods Mol Biol. 2009;481:83\u201396.","journal-title":"Methods Mol Biol"},{"issue":"4","key":"1127_CR24","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/S0021-9258(19)69857-1","volume":"256","author":"M Mourelle","year":"1981","unstructured":"Mourelle M, Rubalcava B. Regeneration of the liver after carbon tetrachloride. Differences in adenylate cyclase and pancreatic hormone receptors. J Biol Chem. 1981;256(4):1656\u201360.","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"1127_CR25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0378-4274(83)90054-1","volume":"17","author":"R Teschke","year":"1983","unstructured":"Teschke R, Vierke W, Goldermann L. Carbon tetrachloride (CCl4) levels and serum activities of liver enzymes following acute CCl4 intoxication. Toxicol Lett. 1983;17(1\u20132):175\u201380.","journal-title":"Toxicol Lett"},{"issue":"2","key":"1127_CR26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0300-483X(92)90156-9","volume":"75","author":"NE Kaminski","year":"1992","unstructured":"Kaminski NE, Stevens WD. The role of metabolism in carbon tetrachloride-mediated immunosuppression. In vitro studies. Toxicology. 1992;75(2):175\u201388.","journal-title":"Toxicology"},{"issue":"8","key":"1127_CR27","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1590\/S0102-86502012000800013","volume":"27","author":"TG Marques","year":"2012","unstructured":"Marques TG, Chaib E, da Fonseca JH, Lourenco AC, Silva FD, Ribeiro MA Jr, Galvao FH, D'Albuquerque LA. Review of experimental models for inducing hepatic cirrhosis by bile duct ligation and carbon tetrachloride injection. Acta Cir Bras. 2012;27(8):589\u201394.","journal-title":"Acta Cir Bras"},{"issue":"1","key":"1127_CR28","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1053\/j.gastro.2017.03.022","volume":"153","author":"A King","year":"2017","unstructured":"King A, Houlihan DD, Kavanagh D, Haldar D, Luu N, Owen A, Suresh S, Than NN, Reynolds G, Penny J, et al. Sphingosine-1-phosphate prevents egress of hematopoietic stem cells from liver to reduce fibrosis. Gastroenterology. 2017;153(1):233\u2013248.e16.","journal-title":"Gastroenterology"},{"issue":"6","key":"1127_CR29","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1002\/hep.20452","volume":"40","author":"I Sakaida","year":"2004","unstructured":"Sakaida I, Terai S, Yamamoto N, Aoyama K, Ishikawa T, Nishina H, Okita K. Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Hepatology. 2004;40(6):1304\u201311.","journal-title":"Hepatology"},{"issue":"1","key":"1127_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/MEG.0b013e32832eb69a","volume":"22","author":"AC Lyra","year":"2010","unstructured":"Lyra AC, Soares MB, da Silva LF, Braga EL, Oliveira SA, Fortes MF, Silva AG, Brustolim D, Genser B, Dos Santos RR, et al. Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: a pilot randomized controlled study. Eur J Gastroenterol Hepatol. 2010;22(1):33\u201342.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"1127_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S2468-1253(17)30326-6","volume":"3","author":"PN Newsome","year":"2018","unstructured":"Newsome PN, Fox R, King AL, Barton D, Than NN, Moore J, Corbett C, Townsend S, Thomas J, Guo K, et al. Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial. Lancet Gastroenterol Hepatol. 2018;3(1):25\u201336.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"7459","key":"1127_CR32","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature12271","volume":"499","author":"T Takebe","year":"2013","unstructured":"Takebe T, Sekine K, Enomura M, Koike H, Kimura M, Ogaeri T, Zhang RR, Ueno Y, Zheng YW, Koike N, et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature. 2013;499(7459):481\u20134.","journal-title":"Nature"},{"issue":"8","key":"1127_CR33","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1161\/CIRCRESAHA.116.305374","volume":"116","author":"T Sadahiro","year":"2015","unstructured":"Sadahiro T, Yamanaka S, Ieda M. Direct cardiac reprogramming: progress and challenges in basic biology and clinical applications. Circ Res. 2015;116(8):1378\u201391.","journal-title":"Circ Res"},{"issue":"3","key":"1127_CR34","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.stem.2014.01.003","volume":"14","author":"P Huang","year":"2014","unstructured":"Huang P, Zhang L, Gao Y, He Z, Yao D, Wu Z, Cen J, Chen X, Liu C, Hu Y, et al. Direct reprogramming of human fibroblasts to functional and expandable hepatocytes. Cell Stem Cell. 2014;14(3):370\u201384.","journal-title":"Cell Stem Cell"},{"issue":"6","key":"1127_CR35","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.stem.2016.01.010","volume":"18","author":"G Song","year":"2016","unstructured":"Song G, Pacher M, Balakrishnan A, Yuan Q, Tsay HC, Yang D, Reetz J, Brandes S, Dai Z, Putzer BM, et al. Direct reprogramming of hepatic myofibroblasts into hepatocytes in vivo attenuates liver fibrosis. Cell Stem Cell. 2016;18(6):797\u2013808.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"1127_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1172\/JCI88881","volume":"127","author":"Y Koyama","year":"2017","unstructured":"Koyama Y, Brenner DA. Liver inflammation and fibrosis. J Clin Invest. 2017;127(1):55\u201364.","journal-title":"J Clin Invest"},{"issue":"4","key":"1127_CR37","doi-asserted-by":"publisher","first-page":"e0196411","DOI":"10.1371\/journal.pone.0196411","volume":"13","author":"S Dutta","year":"2018","unstructured":"Dutta S, Chakraborty AK, Dey P, Kar P, Guha P, Sen S, Kumar A, Sen A, Chaudhuri TK. Amelioration of CCl4 induced liver injury in swiss albino mice by antioxidant rich leaf extract of Croton bonplandianus Baill. PLoS One. 2018;13(4):e0196411.","journal-title":"PLoS One"},{"key":"1127_CR38","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","volume":"53","author":"Q Ma","year":"2013","unstructured":"Ma Q. Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol. 2013;53:401\u201326.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"1127_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0036-1597816","volume":"37","author":"L Campana","year":"2017","unstructured":"Campana L, Iredale JP. Regression of liver fibrosis. Semin Liver Dis. 2017;37(1):1\u201310.","journal-title":"Semin Liver Dis"}],"container-title":["Stem Cell Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-018-1127-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-018-1127-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-018-1127-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T23:55:55Z","timestamp":1720914955000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-018-1127-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,11]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1127"],"URL":"https:\/\/doi.org\/10.1186\/s13287-018-1127-3","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,11]]},"assertion":[{"value":"23 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Mice were handled at the institute\u2019s (Samsung Medical Center Laboratory Animal Research Center, Seoul, Korea) animal facility, and all treatments were in accordance with the legal and institutional guidelines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"21"}}